Electro-catalysis by immobilised human flavin-containing monooxygenase isoform 3 (hFMO3)

被引:21
|
作者
Castrignano, Silvia [1 ]
Sadeghi, Sheila J. [1 ]
Gilardi, Gianfranco [1 ]
机构
[1] Univ Turin, Dept Human & Anim Biol, I-10123 Turin, Italy
关键词
Flavin-containing monooxygenase; Glassy carbon electrode; Glutaraldehyde gel; Bovine serum albumin; GLASSY-CARBON ELECTRODE; ADENINE-DINUCLEOTIDE; N-OXYGENATION; FMO3; POLYMORPHISMS; SENSOR; CYTOCHROME-P450; SPECIFICITY; ENZYME;
D O I
10.1007/s00216-010-4014-z
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Human flavin-containing monooxygenases are the second most important class of drug-metabolizing enzymes after cytochromes P450. Here we report a simple but functional and stable enzyme-electrode system based on a glassy carbon (GC) electrode with human flavin-containing monooxygenase isoform 3 (hFMO3) entrapped in a gel cross-linked with bovine serum albumin (BSA) by glutaraldehyde. The enzymatic electrochemical responsiveness is characterised by using well-known substrates: trimethylamine (TMA), ammonia (NH3), triethylamine (TEA), and benzydamine (BZD). The apparent Michaelis-Menten constant (K'(M)) and apparent maximum current (I'(max)) are calculated by fitting the current signal to the Michaelis-Menten equation for each substrate. The enzyme-electrode has good characteristics: the calculated sensitivity was 40.9 +/- 0.5 mA mol(-1) Lcm(-2) for TMA, 43.3 +/- 0.1 mA mol(-1) Lcm(-2) for NH3, 45.2 +/- 2.2 mA mol(-1) Lcm(-2) for TEA, and 39.3 +/- 0.6 mA mol(-1) Lcm(-2) for BZD. The stability was constant for 3 days and the inter-electrode reproducibility was 12.5%. This is a novel electrochemical tool that can be used to investigate new potential drugs against the catalytic activity of hFMO3.
引用
收藏
页码:1403 / 1409
页数:7
相关论文
共 50 条
  • [1] Electro-catalysis by immobilised human flavin-containing monooxygenase isoform 3 (hFMO3)
    Silvia Castrignanò
    Sheila J. Sadeghi
    Gianfranco Gilardi
    Analytical and Bioanalytical Chemistry, 2010, 398 : 1403 - 1409
  • [2] Catalysis of immobilised human flavin-containing monooxygenase
    Castrignano, S.
    Sadeghi, S.
    Gilardi, G.
    FEBS JOURNAL, 2010, 277 : 262 - 263
  • [3] Flavin-containing monooxygenase 3 and human disease
    Motika, Meike S.
    Zhang, Jun
    Cashman, John R.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2007, 3 (06) : 831 - 845
  • [4] Human flavin-containing monooxygenase 1 and 3 developmental expression
    Koukouritaki, SB
    Yeung, CK
    Rettie, AE
    Williams, DE
    Hines, RN
    FASEB JOURNAL, 2001, 15 (04): : A549 - A549
  • [5] Purification and Characterization of Flavin-Containing Monooxygenase Isoform 3 from Rat Kidney Microsomes
    Novick, Rachel M.
    Elfarra, Adnan A.
    DRUG METABOLISM AND DISPOSITION, 2008, 36 (12) : 2468 - 2474
  • [6] Mutation, polymorphism and perspectives for the future of human flavin-containing monooxygenase 3
    Zhou, Jianhua
    Shephard, Elizabeth A.
    MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2006, 612 (03) : 165 - 171
  • [7] Engineered human Flavin-Containing Monooxygenase 3 on gold nanoparticles electrodes
    Castrignano, S.
    Sadeghi, S. J.
    Gilardi, G.
    FEBS JOURNAL, 2011, 278 : 155 - 155
  • [8] Flavin-containing monooxygenase 3 deficiency -: genotypes and phenotypes
    Zschocke, J
    Guldberg, P
    Wevers, RA
    Santer, R
    Leonard, JV
    Hoffmann, GF
    Kohlmüller, D
    Mayatepek, E
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 : 210 - 210
  • [9] Population distribution of human flavin-containing monooxygenase form 3: Gene polymorphisms
    Cashman, JR
    Zhang, J
    Leushner, J
    Braun, A
    DRUG METABOLISM AND DISPOSITION, 2001, 29 (12) : 1629 - 1637
  • [10] Human flavin-containing monooxygenase (form 3): polymorphisms and variations in chemical metabolism
    Cashman, JR
    PHARMACOGENOMICS, 2002, 3 (03) : 325 - 339